Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies (Q44646952)
Jump to navigation
Jump to search
scientific article published on 6 November 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies |
scientific article published on 6 November 2003 |
Statements
1 reference
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies (English)
1 reference
Hagop M Kantarjian
1 reference
Stefan Faderl
1 reference
Jorge Cortes
1 reference
Guillermo Garcia-Manero
1 reference
Jean-Pierre J Issa
1 reference
Francis J Giles
1 reference
Craig S Rosenfeld
1 reference
Rajan Mannari
1 reference
Deborah Thomas
1 reference
Emel Bayar
1 reference
John Lyons
1 reference
6 November 2003
1 reference
Identifiers
1 reference